Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,815 | -18,496 | -23,365 | -18,849 | N/A |
| Depreciation Amortization | 1,128 | 1,321 | 1,504 | 1,115 | N/A |
| Accounts receivable | -2,375 | -900 | -1,768 | -856 | N/A |
| Accounts payable and accrued liabilities | 1,362 | -954 | 1,542 | -609 | N/A |
| Other Working Capital | -4,972 | -2,369 | 85 | -2,961 | N/A |
| Other Operating Activity | 5,142 | 1,455 | 1,185 | -1,337 | 0 |
| Operating Cash Flow | $-29,530 | $-19,944 | $-20,818 | $-23,496 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -332 | -1,018 | -1,350 | N/A |
| Investing Cash Flow | $-61 | $-332 | $-1,018 | $-1,350 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,113 | N/A | N/A | N/A | N/A |
| Debt Issued | 19,134 | 23,831 | N/A | 6,887 | N/A |
| Debt Repayment | -10,812 | -7,448 | N/A | -5,000 | N/A |
| Common Stock Issued | 20,559 | 19,394 | 14 | 2 | N/A |
| Other Financing Activity | -3,615 | 0 | 17,594 | 23,543 | 0 |
| Financing Cash Flow | $30,379 | $35,776 | $17,608 | $25,431 | $N/A |
| Beginning Cash Position | 16,523 | 1,022 | 5,250 | 4,665 | N/A |
| End Cash Position | 17,311 | 16,523 | 1,022 | 5,250 | N/A |
| Net Cash Flow | $789 | $15,501 | $-4,228 | $585 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,530 | -19,944 | -20,818 | -23,496 | N/A |
| Capital Expenditure | -61 | -332 | -1,018 | -1,350 | N/A |
| Free Cash Flow | -29,591 | -20,276 | -21,836 | -24,846 | 0 |